Eagle Asset Management Inc Neurocrine Biosciences Inc Transaction History
Eagle Asset Management Inc
- $16.7 Billion
- Q3 2024
A detailed history of Eagle Asset Management Inc transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Eagle Asset Management Inc holds 621,363 shares of NBIX stock, worth $84.9 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
621,363
Previous 680,034
8.63%
Holding current value
$84.9 Million
Previous $93.6 Million
23.59%
% of portfolio
0.43%
Previous 0.52%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
627Shares Held
94.2MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$1.94 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.37 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$704 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$352 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$255 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.1B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...